Fundraising Fox
/Companies
Sign in

Biocartesian

YC S24

San Francisco, US · Founded 2023 · 2 employees · 5 known investors

Find your way into Biocartesian

Sign up to see every warm intro you have to Biocartesian

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Biocartesian team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Biocartesian provides optical pooled screening services for functional genomics research. The company uses its proprietary ARADIA technology to link microscopy-based cellular phenotypes with genetic perturbations, enabling researchers to conduct large-scale CRISPR screens and other genomic studies with visual, spatial, and live-cell readouts.

Also known as coordna bio, Inc. · coordna bio

AI & Machine LearningBiotechDeep TechHealthtechHard TechB2BDiagnosticsDrug discoveryUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S24)

Biocartesian was founded in 2023 by Ian Dardani and Jess Li.

IDIan Dardani
Ian DardaniCo-founder & CEOHe previously worked at Cambridge's Bioscience Enterprise and holds a PhD in Bioengineering from the University of Pennsylvania.
JLJess Li
Jess LiCo-founder & CSOShe holds a PhD from University of Pennsylvania and previously worked in business development at Imvaria.

Investors · 5

Agrolimen Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

GGrisereported

How we know: Y Combinator's founder network · Not right? Tell us

Metsu Capitalreported

How we know: Y Combinator's founder network · Not right? Tell us

Preston-Werner VenturesreportedSan Francisco Bay Area · $500K – $3M

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 5

Cofactor GenomicsCofactor Genomics develops predictive diagnostics for cancer immunotherapy using RNA-expression models to characterize tumor microenvironments and predict patient response. The company serves oncology and precision medicine markets by enabling more accurate patient-to-therapy matching.
NumenNumen develops at-home cancer diagnostics and health data collection infrastructure using machine learning models to enable earlier intervention and improve patient outcomes.
One CodexOne Codex provides microbiome sequencing data analysis and reporting software for academic labs, biotechnology companies, and clinical laboratories. The platform uses advanced algorithms and a curated database to analyze metagenomic samples with a web-based interface accessible to both bench scientists and computational biologists.
Signatur BiosciencesSignatur Biosciences develops molecular diagnostic solutions using qPCR technology for in vitro diagnostics, targeting clinical and laboratory markets. The company aims to deliver advanced diagnostics on widely available instrumentation to expand access to cutting-edge healthcare globally.
IsablIsabl develops whole genome and transcriptome sequencing technology for cancer diagnosis, delivering comprehensive genomic profiling and treatment options to physicians and research teams. The company provides rapid cancer diagnostic tests in clinically relevant timeframes to improve outcomes for cancer patients globally.

Companies working in the same space as Biocartesian.

Legal entities · 1

corporate structure
coordna bio, Inc.

In the news

Biocartesian - Converting biology into digital molecular mapsycombinator.com · Aug 2024Biocartesian Funding | Complete Analysis | Extruct AIextruct.ai

Frequently asked questions

What does Biocartesian do?
Biocartesian provides optical pooled screening services for functional genomics research. The company uses its proprietary ARADIA technology to link microscopy-based cellular phenotypes with genetic perturbations, enabling researchers to conduct large-scale CRISPR screens and other genomic studies with visual, spatial, and live-cell readouts.
Who founded Biocartesian?
Biocartesian was founded by Ian Dardani, Jess Li in 2023.
Who are Biocartesian's investors?
Biocartesian's investors include Y Combinator, Agrolimen Ventures, GGrise, Metsu Capital, Preston-Werner Ventures.
Where is Biocartesian headquartered?
Biocartesian is headquartered in San Francisco, US.